Bringing you live news and features since 2006 

Solactive reports on Cathay Securities genomics ETF

RELATED TOPICS​

Frankfurt-based index provider Solactive writes that in the wake of its massive negative impacts, the pandemic has accelerated the development of new pharmaceuticals and vaccines. 

“For example, mRNA-based pharmaceuticals, whose technology originated in the late 60s of the previous century, finally reached approval status, and its potential usage far exceeds its current application as an effective vaccine against SARS-COVID-19. Cathay Securities Investment Trust, one of the largest Taiwanese asset managers, has now launched an ETF, tracking companies pioneering in the development of innovative medication. 

“The ETF, the Cathay Global Genomics Immunology and Medical Revolution ETF (Stock Code: 00898), started trading on Taiwan Stock Exchange on 22nd November 2021, with IPO listing assets of around USD130 million. The ETF tracks the Solactive Global Genomics Immunology and Medical Revolution Index (SOLGIMRN).”

Solactive writes that according to a recent study, genomics technology holds the potential to generate revenues of USD54.4 billion by 2025 from USD22.7 billion in 2020, growing at a CAGR of 19.0 per cent during the forecast period. The firm says that this market expectation implies the tremendous potential that this cutting-edge technology cocoons, and as a sideline, denotes the capability it holds to revolutionise not only the entire biotechnology sector, but also the way humanity treats illnesses. The Solactive Global Genomics Immunology and Medical Revolution Index serves as a representation of companies that have business operations in the biotechnology and genomics industry, the firm says.
Companies that are eligible for index inclusion must be classified as, for example, Pharmaceuticals, Biotechnology, Medical Specialties, or Managed Health Care, according to conventional Industries and Economic Sectors classification systems. If a company qualifies in this context, Solactive executes a greater in-depth analysis to reveal the candidate’s relevance to the respective theme. To derive a company’s significance, Solactive’s proprietary ARTIS engine screens publicly available information such as financial websites, regulatory filings, or company publications using its natural language processing algorithm.

“The pandemic has put global medical sectors into the spotlight, and many pharmaceutical revolutions originated in the previous 18 months with genomics technology and personalised medicine being part of a much broader and auspicious trend,” comments Timo Pfeifer, Chief Markets Officer at Solactive. ”With major player Cathay, we are very honoured to expand our APAC footprint to Taiwan, and we are looking forward to establishing a longstanding business relationship with them, developing more innovative products together in the future.”

“In the past two years, we’ve seen the importance of medical investment, and we believe health is the biggest wealth for everyone. Thus, we’re so honored to cooperate with the German thematic index expert Solactive to bring Cathay Genomics Immunology and Medical Revolution ETF to Taiwan market to provide investors an indispensable vehicle to their portfolio that invest in companies with revolutionary medical technologies. As the biggest asset management company in Taiwan, it’s always important to have partners like Solactive to offer better opportunities to our investors and to keep our leading position,” says Eddie Cheng, Head of Quantitative and Index Business Division.
 

Latest News

Saving and investing app, Moneybox, has doubled the number of ETFs available on the platform, in the light of ‘growing..
Global X ETFs has announced the appointment of Ryan O'Connor as its Chief Executive Officer effective as of April 8, 2024. ..
Value-driven structured credit investing firm, Angel Oak Capital Advisors, LLC, has announced the completed conversions of two of its mutual..
Confidence in the continuing strength of bitcoin and Ethereum is driving wider interest in altcoins and other digital assets, according..

Related Articles

Graham MacKenzie, Toronto Stock Exchange
The evolution of ETFs has been a multi-decade experience for Toronto Stock Exchange says Graham MacKenzie, managing director, Exchange Traded...
Frank Koudelka, State Street Global Services
ETF data provider and ETF Express data partner, Trackinsight, has published its Global ETF Survey 2024 Report: ‘50+ Charts on...
Cryptocurrencies
Matteo Greco, Research Analyst at Fineqia International writes that bitcoin (BTC) ended the week at approximately USD52,150, showing a notable...
US Distribution Awards trophies
The winners of the first US ETF Distribution Awards at the Exchange conference, hosted by ETF Express and sponsored by...
Subscribe to the ETF Express newsletter

Subscribe for access to our weekly newsletter, newsletter archive, updates on the site and exclusive email content.

Marketing by